|
Report No. : |
349835 |
|
Report Date : |
25.11.2015 |
IDENTIFICATION DETAILS
|
Name : |
SARTORIUS STEDIM BIOTECH GMBH |
|
|
|
|
Registered Office : |
August-Spindler-Str. 11, D 37079
Göttingen |
|
|
|
|
Country : |
Germany |
|
|
|
|
Financials (as on) : |
31.12.2014 |
|
|
|
|
Date of Incorporation : |
29.11.2006 |
|
|
|
|
Com. Reg. No.: |
HRB 200266 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
·
Wholesale
of pharmaceutical goods ·
Management
of holding companies ·
Other
activities of head offices ·
Business
and other management consultancy activities |
|
|
|
|
No. of Employees : |
1,088 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made on
e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GERMANY - ECONOMIC
OVERVIEW
The German economy - the fifth largest economy in the world
in PPP terms and Europe's largest - is a leading exporter of machinery,
vehicles, chemicals, and household equipment and benefits from a highly skilled
labor force. Like its Western European neighbors, Germany faces significant
demographic challenges to sustained long-term growth. Low fertility rates and
declining net immigration are increasing pressure on the country's social
welfare system and necessitate structural reforms. Reforms launched by the
government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to
address chronically high unemployment and low average growth, contributed to
strong growth and falling unemployment. These advances, as well as a government
subsidized, reduced working hour scheme, help explain the relatively modest
increase in unemployment during the 2008-09 recession - the deepest since World
War II - and its decrease to 5.2% in 2014. The new German government introduced
a minimum wage of about $11.60 (8.50 euros) per hour to take effect in 2015.
Stimulus and stabilization efforts initiated in 2008 and 2009 and tax cuts
introduced in Chancellor Angela MERKEL's second term increased Germany's total
budget deficit - including federal, state, and municipal - to 4.1% in 2010, but
slower spending and higher tax revenues reduced the deficit to 0.8% in 2011 and
in 2012 Germany reached a budget surplus of 0.1%. The budget was essentially in
balance in 2014. A constitutional amendment approved in 2009 limits the federal
government to structural deficits of no more than 0.35% of GDP per annum as of
2016 though the target was already reached in 2012. The German economy suffers
from low levels of investment, and a government plan to invest 15 billion euros
2016-18, largely in infrastructure, is intended to spur needed private
investment. Following the March 2011 Fukushima nuclear disaster, Chancellor
Angela MERKEL announced in May 2011 that eight of the country's 17 nuclear
reactors would be shut down immediately and the remaining plants would close by
2022. Germany plans to replace nuclear power with renewable energy, which
accounted for 27.8% of gross electricity consumption in 2014, up from 9% in
2000. Before the shutdown of the eight reactors, Germany relied on nuclear power
for 23% of its electricity generating capacity and 46% of its base-load
electricity production. Extremely low inflation, caused largely by low global
energy prices and a weak euro, are expected to boost German GDP growth in 2015.
|
Source
: CIA |
SARTORIUS
STEDIM BIOTECH GMBH
Company Status: active
August-Spindler-Str. 11
D 37079 Göttingen
Telephone:0551/3080
Telefax: 0551/3083289
E-mail: info@sartorius-stedim.com
VAT
no.: DE899007997
Business relations are permissible.
LEGAL FORM Private
limited company
Date of foundation: 29.11.2006
Shareholders'
agreement: 29.11.2006
Registered on: 22.03.2007
Commercial Register: Local court 37073 Göttingen
under: HRB
200266
EUR 6,000,000.00
Shareholder:
Sartorius Stedim Biotech
S.A.
Avenue de Jouques
F 13400 Aubagne
Legal form: Other legal
form
Share: EUR 6,000,000.00
Manager:
Uwe Becker
D 37127 Dransfeld
born: 09.04.1962
Manager:
Dr. René Fáber
D 37079 Göttingen
born: 18.07.1975
President of the Supervisory Board:
Prof. Dr. Dres. h.c.
Arnold Picot
D 37075 Göttingen
Marital status: unknown
Vice-president of the Supervisory Board:
Dr. rer. pol. Joachim
Kreuzburg
D 30159 Hannover
born: 22.04.1965
Marital status: unknown
Member of the Supervisory Board:
Dietmar Günther Müller
Burgkamp 15
D 31228 Peine
born: 12.03.1962
Proxy:
Jens Michael Artelt
Am hohlen Wege 31
D 37124 Rosdorf
authorized to jointly
represent the company
born: 17.12.1971
Marital status: unknown
Proxy:
Jörg Pfirrmann
D 37176 Nörten-Hardenberg
authorized to jointly
represent the company
born: 30.11.1972
Further functions/participations of Uwe Becker
(Manager)
Manager:
Sartorius Stedim Plastics
GmbH
Karl-Arnold-Str. 21
D 37079 Göttingen
Legal form: Private
limited company
Share capital: EUR 255,650.00
Registered
on: 17.12.1985
Reg. data: 37073 Göttingen, HRB 1551
29.11.2006
- 22.03.2007 Soho
Beteiligungsgesellschaft mbH (AG
Frankf./M. HRB 78842)
Senckenberganlage 16
D 60325 Frankfurt
Private limited
company
22.03.2007
- 27.03.2007 Soho
Beteiligungsgesellschaft mbh
August-Spindler-Str.
11
D 37079 Göttingen
Private limited
company
03.06.2009
- 21.03.2015 Manager
Dr. Oscar-Werner Reif
D 30159 Hannover
02.04.2007 - 21.03.2015 Manager
Volker Niebel
D 37077 Göttingen
02.04.2007 - 21.03.2015 Manager
Reinhard Vogt
D 37127 Dransfeld
Main industrial sector
46461
Wholesale of pharmaceutical goods
70101
Management of holding companies
70109
Other activities of head offices
70220
Business and other management consultancy activities
Shareholder:
Sartorius Stedim Systems
GmbH
Robert-Bosch-Str. 5-7
D 34302 Guxhagen
Legal form: Private
limited company
Company Status: active
Share capital: EUR 5,625,000.00
Share: EUR 5,625,000.00
Reg. data: 22.01.1988
Local court
34560 Fritzlar
HRB 11105
Shareholder:
Sartorius Stedim Plastics
GmbH
Karl-Arnold-Str. 21
D 37079 Göttingen
Legal form: Private
limited company
Company Status: active
Share capital: EUR 255,650.00
Share: EUR 255,650.00
Reg. data: 17.12.1985
Local court
37073 Göttingen
HRB 1551
Shareholder:
Distribo GmbH
Groner Siekanger 1
D 37081 Göttingen
Legal form: Private
limited company
Company Status: active
Share capital: EUR 400,000.00
Share: EUR 104,000.00
Reg. data: 10.04.2003
Local court
37073 Göttingen
HRB 3686
Shareholder:
CELLCA GmbH
Uhlmannstr. 28
D 88471 Laupheim
Legal form: Private
limited company
Company Status: active
Share capital: EUR 100,000.00
Share: EUR 72,841.00
Reg. data: 01.12.2005
Local court
89073 Ulm
HRB 641938
Payment experience: within agreed terms
Negative information:We have no negative
information at hand.
Balance sheet year: 2014
Type of ownership: Tenant
Address August-Spindler-Str.
11
D 37079 Göttingen
Land register documents were not available.
Principal bank
COMMERZBANK, 37005 GÖTTINGEN, NIEDERSACHS
Sort. code: 26040030, Account no.: 6227250
BIC: COBADEFFXXX, IBAN: DE72260400300622725000
Turnover: 2013 EUR 283,912,550.00
2014 EUR 312,386,885.00
Profit: 2013 EUR 32,993,203.00
2014 EUR 16,141,474.00
further business figures:
Ac/ts receivable: EUR 111,230,903.00
Liabilities: EUR 296,823,666.00
Employees:
1,088
Balance
sheet ratios 01.01.2014 - 31.12.2014
Equity ratio [%]: 12.65
Liquidity ratio: 0.25
Return on total capital [%]: 4.36
Balance sheet ratios 01.01.2013 - 31.12.2013
Equity ratio [%]: 13.20
Liquidity ratio: 0.24
Return on total capital [%]: 8.84
Balance
sheet ratios 01.01.2012 - 31.12.2012
Equity ratio [%]: 22.79
Liquidity ratio: 0.40
Return on total capital [%]: 9.73
Balance sheet ratios 01.01.2011 - 31.12.2011
Equity ratio [%]: 12.09
Liquidity ratio: 0.32
Return on total capital [%]: 7.11
Equity ratio
The
equity ratio indicates the portion of the equity as compared
to
the total capital. The higher the equity ratio, the better the
economic stability (solvency) and thus the
financial autonomy of
a
company.
Liquidity ratio
The
liquidity ratio shows the proportion between adjusted
receivables and net liabilities. The higher
the ratio, the lower
the
company's financial dependancy from external creditors.
Return on total capital
The
return on total capital shows the efficiency and return on
the
total capital employed in the company. The higher the return
on
total capital, the more economically does the company work
with the invested capital.
Type
of balance
sheet: Company balance sheet
Origin of the present
balance sheet: electronic German Federal Gazette
Financial year: 01.01.2014 - 31.12.2014
ASSETS EUR 431,930,347.79
Fixed assets
EUR 277,734,468.94
Intangible assets
EUR 43,310,773.00
Tangible assets
EUR 101,709,266.67
Financial assets
EUR 132,714,429.27
Other / unspecified financial assets EUR 132,714,429.27
Current assets
EUR 153,998,989.74
Stocks
EUR 35,172,230.41
Accounts receivable
EUR 111,230,902.53
Trade debtors
EUR 15,379,000.00
Amounts due from related companies
EUR 90,070,000.00
Other debtors and assets
EUR 5,781,902.53
Liquid means
EUR 7,595,856.80
Remaining other assets
EUR 196,889.11
Accruals (assets)
EUR 196,889.11
LIABILITIES EUR 431,930,347.79
Shareholders' equity EUR 108,553,258.50
Capital
EUR 6,000,000.00
Subscribed capital (share capital)
EUR 6,000,000.00
Reserves
EUR 53,627,921.14
Capital reserves
EUR 53,627,921.14
Balance sheet profit/loss (+/-)
EUR 48,925,337.36
Balance sheet profit / loss
EUR 48,925,337.36
Provisions
EUR 26,553,423.18
Liabilities EUR 296,823,666.11
Financial debts
EUR 21,948,000.00
Liabilities due to banks
EUR 21,948,000.00
Other liabilities
EUR 274,875,666.11
Trade creditors (for IAS incl. bills
of exchange)
EUR 7,334,000.00
Liabilities from received advance
payments
EUR 593,000.00
Liabililties due to related companiesEUR 222,546,000.00
Unspecified other liabilities
EUR 44,402,666.11
PROFIT AND LOSS ACCOUNT (cost-summary method)
according to Comm.
Code
(HGB)
Sales
EUR 312,386,884.97
Inventory change + own costs (+/-)
EUR 938,724.53
Inventory change (+/-)
EUR -512,242.78
Capitalised own costs
EUR 1,450,967.31
Other operating income
EUR 19,154,640.82
Cost of materials
EUR 133,783,909.02
Gross result (+/-)
EUR 198,696,341.30
Staff expenses
EUR 71,477,389.64
Total depreciation
EUR 11,849,388.04
Other operating expenses
EUR 90,213,545.52
Operating result from continuing
operations
EUR 25,156,018.10
Result from participating interests
(+/-) EUR 11,556,778.44
Expenses / income from participations EUR 11,556,778.44
Income from related companies
EUR 11,556,778.44
Interest result (+/-)
EUR -8,786,343.47
Interest and similar income
EUR 2,520,524.55
Interest and similar expenses
EUR 11,306,868.02
Financial result (+/-)
EUR 2,770,434.97
Result from ordinary operations (+/-)
EUR 27,926,453.07
Income from assumption of loss by
parent company
EUR 11,505,577.93
Expenses for transfer of profits to a
parent company
EUR 1.00
Income tax / refund of income tax (+/-)EUR -11,446,585.13
Other taxes / refund of taxes
EUR -338,394.31
Tax
(+/-)
EUR -11,784,979.44
Annual surplus / annual deficit
EUR 27,647,050.56
Type
of balance
sheet: Company balance sheet
Origin of the present
balance sheet: self-disclosure
Financial year: 01.01.2013 - 31.12.2013
ASSETS EUR 441,466,025.64
Fixed assets
EUR 272,452,546.45
Intangible assets
EUR 46,822,387.00
Tangible assets
EUR 89,126,461.23
Financial assets
EUR 136,503,698.22
Other / unspecified financial assets EUR 136,503,698.22
Current assets
EUR 167,372,758.87
Stocks
EUR 35,400,507.65
Accounts receivable
EUR 114,875,229.06
thereof total due from shareholders
EUR 44,699,000.00
Liquid means
EUR 17,097,022.16
Remaining other assets
EUR 1,640,720.32
Accruals (assets)
EUR 1,640,720.32
LIABILITIES
EUR 441,466,025.64
Shareholders' equity
EUR 104,906,206.94
Capital
EUR 6,000,000.00
Subscribed capital (share capital)
EUR 6,000,000.00
Reserves EUR 53,627,921.14
Capital reserves
EUR 53,627,921.14
Balance sheet profit/loss (+/-)
EUR 45,278,285.80
Balance sheet profit / loss
EUR 45,278,285.80
Provisions
EUR 17,632,317.89
Liabilities
EUR 318,927,500.81
thereof total due to shareholders
EUR 12,491,000.00
Financial debts
EUR 122,596,000.00
Liabilities due to banks
EUR 122,596,000.00
Other liabilities
EUR 196,331,500.81
Trade creditors (for IAS incl. bills
of exchange)
EUR 8,717,000.00
Liabilities from received advance
payments
EUR 379,000.00
Liabililties due to related companiesEUR 141,008,000.00
Liabilities due to investee companiesEUR 354,000.00
Unspecified
other liabilities EUR 45,873,500.81
thereof liabilities from tax /
financial authorities
EUR 1,657,000.00
thereof liabilities from social
security
EUR 0.00
Guarantees and other commitments
EUR 1,895,000.00
Guarantees / warranties
EUR 1,895,000.00
Guarantees
EUR 1,895,000.00
PROFIT AND LOSS ACCOUNT (cost-summary method)
according to Comm.
Code
(HGB)
Sales
EUR 283,912,549.68
Inventory change + own costs (+/-)
EUR 1,322,934.87
Inventory change (+/-)
EUR 612,269.39
Capitalised own costs
EUR 710,665.48
Other operating income
EUR 20,123,489.14
Cost of materials
EUR 119,635,574.77
Gross result (+/-)
EUR 185,723,398.92
Staff
expenses EUR 65,461,849.66
Total depreciation
EUR 12,412,272.20
Other operating expenses
EUR 68,819,434.15
Operating result from continuing
operations EUR 39,029,842.91
Result from participating interests
(+/-)
EUR 8,935,920.42
Expenses / income from participations EUR 8,935,920.42
Income from related companies
EUR 8,935,920.42
Expenses for the transfer of losses
EUR 136,069.76
Interest result (+/-)
EUR -3,289,057.15
Interest and similar income
EUR 2,767,081.30
Interest and similar expenses
EUR 6,056,138.45
Financial result (+/-)
EUR 5,510,793.51
Result from ordinary operations (+/-)
EUR 44,540,636.42
Income tax / refund of income tax (+/-)EUR -11,401,975.64
Other taxes / refund of taxes
EUR -145,457.60
Tax
(+/-)
EUR -11,547,433.24
Annual surplus / annual deficit
EUR 32,993,203.18
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.35 |
|
|
1 |
Rs.100.66 |
|
Euro |
1 |
Rs.70.47 |
INFORMATION DETAILS
|
Analysis Done by
: |
KIN |
|
|
|
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.